PARMAR KUSH
All 5 shown
- Entrada Therapeutics, Inc. Director$647,108Open-market sale
- Entrada Therapeutics, Inc. Director$358,371Open-market sale
- Entrada Therapeutics, Inc. Director$73,458Open-market sale
- Entrada Therapeutics, Inc. Director, 10% owner$11,768Open-market sale
- Entrada Therapeutics, Inc. Director, 10% owner$795,259Open-market sale